NSEDividend5d ago · 26 Oct 2026, 05:38 pm

Dividend

DCM Shriram Limited · DCMSHRIRAM

✦ AI SummaryDividend

DCM Shriram Limited has declared an interim dividend of Rs. 4 per equity share, approved unaudited financial results for the quarter and half year ended 30th September 2026, and made several other announcements including the appointment of a new nominee director, equity contribution to a joint venture, and capital expenditures.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

DCM Shriram Limited has informed the Exchange that Board of Directors at its meeting held on October 26, 2026, declared Interim Dividend of Rs. 4 per equity share.

Attachments (1)

📄

DCMSHRIRAM_26102026173816_FinalOutcome26Oct2026SIGNED.pdf

pdf

Download →
View document text
DCM SHRIRAM 26th October 2026 BSE Limited National Stock Exchange of India Limited Phiroze JeeJeeBhoy Towers, Exchange Plaza, 5th Floor, Plot No. C-1, Dalal Street, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai - 400 001 Mumbai - 400 051 SCRIP CODE: 523367 SCRIP CODE: DCMSHRIRAM Sub: Outcome of Board Meeting - Unaudited Financial Results (Standalone and Consolidated) for the Quarter/Half Year ended 30th September 2026 – other Disclosures under Regulation 30 Dear Sirs/Madam, Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we inform you that the Board of Directors of the Company, at its meeting held today, i.e., on 26th October 2026, has, inter-alia, approved: I. Unaudited Financial Results (both Standalone and Consolidated) for the quarter and half year ended 30th September 2026. The copies of said Unaudited Financial Results along with Limited Review Reports thereon of Statutory Auditors, Deloitte Haskins & Sells, Chartered Accountants, are enclosed herewith as Annexure – I; II. Declaration of Interim Dividend for the Financial Year 2026-27 on the paid-up equity share capital of the Company @ 200% (₹4/- per Equity share of face value of ₹. 2/- each). As already intimated, vide our Intimation dated 19th October 2026, the Record Date for the purpose of the said Interim Dividend shall be Friday, 30th October 2026. Further, the said Interim Dividend shall be paid to all eligible shareholders within 30 days from the date of declaration of dividend. III. Pursuant to letter received from Life Insurance Corporation of India (“LIC”) regarding change of its nominee on the Board of the Company, and on recommendation of the Nomination, Remuneration and Compensation Committee, the Board of Directors has approved the appointment of Mr. Salil Vishwanath (DIN yet to be allotted) as Nominee Director of LIC effective from 1st November 2026 or from the date of allotment of Director Identification Number (DIN), whichever is later, in place of Mr. Rabinarayan Mishra (DIN:10377015), subject to approval of the shareholders of the Company. Accordingly, Mr. Rabinarayan Mishra will cease to be director of the Company effective from 1st November 2026. There is no other material reason for cessation of Mr. Rabinarayan Mishra as Nominee Director on the Board of the Company. Further, Mr. Salil Vishwanath is not debarred from holding the office of Director pursuant to any Order of SEBI, MCA or any such authority. DCM SHRIRAM LTD. Corporate Office: 2nd Floor (West Wing), Worldmark 1, Aerocity, New Delhi -110037, India Tel: +91 11 42100200 Registered Office: Plot No. 82, Sector 32, Institutional Area, Gurugram - 122 001, Haryana, India Tel: +91 124 4513700 e-mail: response@dcmshriram.comwebsite:www.dcmshriram.com GIN: L74899HR1989PLC137147 Shriram Fertilisers & Chemicals • Shriram Alkali & Chemicals • DCM Shriram Sugar • Bioseed • Fenesta Building Systems • Shriram Cement DCM SHRIRAM Details as required under the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January 2026 are given in Annex- II. IV. Equity contribution of upto ₹50 crores in Shriram Teknor Limited (STL), a Joint Venture between the Company and Teknor Apex B.V., towards its capital investment of upto ₹133 crores for setting up new manufacturing lines for the manufacture of speciality PVC grades, speciality medical grades and diversification into the manufacture of Halogen- Free Flame Retardant (HFFR) grades. Capital investment is proposed to be met through equity contribution of ₹50 crores by each of the JV partners of STL and the balance amount would be met by STL through internal cash generation and debt funding. Details as required under the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January 2026 are given in Annex- III. V. Capital expenditure of upto ₹60 crores towards installation of the Filter Presses at Cement Plant in Kota with a view to mitigating losses in the Cement Plant and providing greater operational flexibility in handling sludge. VI. Capital expenditure of upto ₹145 crores towards installation of Solar Power Plant at Kota complex of the Company to meet the power requirement of its Vinyl Plant. This will enable the Company to meet its power requirement of upto 8 MW in cost effective manner, which is being presently met through grid power, where the cost per unit is high as compared to solar power. VII. Purchase of one additional electrolyser each for Kota and Bharuch Caustic plants at capital expenditure of upto ₹120 crores to debottleneck these plants. The Board meeting commenced at 2:15 P.M and concluded at 4:15 P.M. Kindly take the above information on record. The same is available on the Company’s website i.e., https://www.dcmshriram.com/. Thanking you, Yours faithfully, For DCM Shriram Limited (Deepak Gupta) Company Secretary & Compliance Officer Encl.: a/a DCM SHRIRAM LTD. Corporate Office: 2nd Floor (West Wing), Worldmark 1, Aerocity, New Delhi -110037, India Tel: +91 11 42100200 Registered Office: Plot No. 82, Sector 32, Institutional Area, Gurugram - 122 001, Haryana, India Tel: +91 124 4513700 e-mail: response@dcmshriram.comwebsite:www.dcmshriram.com GIN: L74899HR1989PLC137147 Shriram Fertilisers & Chemicals • Shriram Alkali & Chemicals • DCM Shriram Sugar • Bioseed • Fenesta Building Systems • Shriram Cement Chartered Accountants Deloitte 7th Floor, Building 10, Tower B, DLF Cyber City Complex, Haskins & Sells DLF City Phase II, Gurugram - 122 002 Haryana, India Phone: +91 124 679 2000 Fax: +91 124 679 2012 INDEPENDENT AUDITOR'S REVIEW REPORT ON REVIEW OF INTERIM STANDALONE FINANCIAL RESULTS TO THE BOARD OF DIRECTORS OF DCM SHRIRAM LIMITED 1. We have reviewed the accompanying Statement of Standalone Unaudited Financial Results of DCM SHRIRAM LIMITED {the "Company"), for the quarter and half year ended September 30, 2026 {the "Statement"), being submitted by the Company pursuant to the requirement of Regulation 33 and Regulation 52 of the SEBI {Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended {the "LODR Regulations"). 2. This Statement, which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" {"Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 and Regulation 52 of the LODR Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements {SRE) 2410 'Reviewoflnterim Financial Information Performed by the Independent Auditor of the Entity', issued by the Institute of Chartered Accountants of India {ICAI}. A review of interim financial information consists of making inquiries, primarily of the Company's personnel responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10} of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting prin [Showing first 8,000 characters — download PDF for full document]